PRESS RELEASE published on 07/01/2025 at 07:30, 1 year ago Inside Information / Other news releases Sensorion announces positive data from the first cohort of the Audiogene Phase 1/2 Gene Therapy Clinical Trial, showing safety and hearing improvement in toddlers. Second cohort recruitment near completion Gene Therapy Clinical Trial Sensorion Audiogene Hearing Improvement
PRESS RELEASE published on 07/01/2025 at 07:30, 1 year ago Informations privilégiées / Autres communiqués Sensorion annonce des données préliminaires positives de la première cohorte de l'essai clinique de Phase 1/2 de thérapie génique Audiogene évaluant le SENS-501 pour traiter une forme spécifique de surdité congénitale Sécurité Thérapie Génique Sensorion Surdité Audiogene
BRIEF published on 05/13/2025 at 07:35, 1 year 1 month ago Sensorion Announces Approval of Shareholders’ Meeting Resolutions Biotechnology Gene Therapy Shareholder Resolutions Sensorion Hearing Loss Therapy
BRIEF published on 05/13/2025 at 07:35, 1 year 1 month ago Sensorion annonce l'approbation des résolutions de l'assemblée générale des actionnaires Biotechnologie Thérapie Génique Sensorion Résolutions Des Actionnaires Thérapie De La Perte Auditive
PRESS RELEASE published on 05/13/2025 at 07:30, 1 year 1 month ago Informations privilégiées / Autres communiqués Sensorion publie les résultats de l’AGM avec adoption de toutes les résolutions recommandées par le CA. Détails des votes disponibles en ligne Biotechnologie Résultats Assemblée Générale Mixte Sensorion Thérapie Auditive
PRESS RELEASE published on 05/13/2025 at 07:30, 1 year 1 month ago Inside Information / Other news releases Sensorion announces successful adoption of all resolutions at Combined General Meeting. Results available on company's website Biotechnology Resolutions Combined General Meeting Sensorion Hearing Loss
BRIEF published on 05/06/2025 at 07:35, 1 year 1 month ago Sensorion to Present at ASGCT Annual Meeting Gene Therapy Sensorion Hearing Loss ASGCT Meeting DFNB1A
BRIEF published on 05/06/2025 at 07:35, 1 year 1 month ago Sensorion présentera à la réunion annuelle de l'ASGCT Thérapie Génique Sensorion Perte Auditive DFNB1A Réunion De L'ASGCT
PRESS RELEASE published on 05/06/2025 at 07:30, 1 year 1 month ago Inside Information / Other news releases Sensorion announces participation at ASGCT Annual Meeting to present gene therapy research for hearing loss. Company focuses on developing innovative therapies. ASGCT 28th meeting details included Research Gene Therapy ASGCT Sensorion Hearing Loss
PRESS RELEASE published on 05/06/2025 at 07:30, 1 year 1 month ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à la conférence annuelle de l'ASGCT pour présenter ses avancées en thérapie génique et cellulaire pour la surdité. Détails des posters et programme de développement dévoilés Innovation Thérapie Génique ASGCT Sensorion Perte Auditive
Published on 07/03/2026 at 23:00, 20 hours 52 minutes ago Eagle Plains Partner Refined Energy Announces Final Results for Winter 2026 Drill Program at Dufferin West
Published on 07/03/2026 at 21:28, 22 hours 24 minutes ago Trifecta Gold Announces Closing of $1.66 Million Private Placement
Published on 07/03/2026 at 19:30, 1 day ago Polaris Renewable Energy Announces Q2 2026 Investor Call Details
Published on 07/03/2026 at 13:30, 1 day 6 hours ago Nextech3D.ai Unveils Strategic AI Growth Roadmap Focused on Workforce Intelligence and Event Technology Innovation
Published on 07/04/2026 at 17:35, 2 hours 17 minutes ago Vantage Introduces 24/7 Gold CFD Trading with XAUUSD247
Published on 07/04/2026 at 11:01, 8 hours 51 minutes ago EQS-Adhoc: Continental AG: Continental AG Sells ContiTech Group Sector
Published on 07/04/2026 at 09:05, 10 hours 47 minutes ago Velo x McLaren Mastercard Formula 1® Team Relaunches Live Your Fandom to Bring Fans Closer to the Sport They Love
Published on 07/03/2026 at 19:00, 1 day ago PATRIMOINE ET COMMERCE: BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE AU 30 JUIN 2026
Published on 07/03/2026 at 18:55, 1 day ago Saudia Arabia's Mabani Aljazeera Group invests in Tatu City's Jabali Towers development
Published on 07/03/2026 at 21:49, 22 hours 3 minutes ago Safran annonce la fin des négociations concernant le projet d'acquisition d’Exail Technologies.
Published on 07/03/2026 at 21:49, 22 hours 3 minutes ago Safran announces the end of negotiations regarding the contemplated acquisition of Exail Technologies.
Published on 07/03/2026 at 18:42, 1 day 1 hour ago Total number of voting rights and shares making up the share capital at June 30, 2026
Published on 07/03/2026 at 18:36, 1 day 1 hour ago Disclosure of transactions in own shares from July 1 to July 3, 2026
